Variables | Na | Selected examples | References |
---|---|---|---|
Socio-demographic | 66 | Â | Â |
 Race and/or ethnicity | 17 |  | |
 Patients’ age | 16 | Young: ≤ 45 years old, Older: > 45 years old | |
 Gender | 12 |  | |
 Obesity / weight related | 7 |  |  |
  - Body mass index / obesity | 6 |  | |
  - Waist circumference | 1 |  | [59] |
  - Weight change over time | 1 |  | [104] |
 Lifestyle factors | 6 |  |  |
  - Level / patterns of physical activity | 4 |  | |
  - Lifestyle patterns | 3 | Morningness-eveningness, sleep quality, Consumption of food, alcohol and cigarettes [106] | |
 Dietary factors / patterns | 6 | e.g. intake of coffee, high fat dietary pattern score | |
 Education related | 4 |  |  |
  - Level of literacy | 2 |  | |
  - Level of health literacy | 1 |  | [18] |
  - Verbal intelligence | 1 | Groningen Intelligence Test [113] | [113] |
 Economic related factors | 4 |  |  |
  - Household income | 2 |  | |
  - Socio-economic status of patients | 1 |  | [115] |
  - Employment status | 1 |  | [107] |
 Smoking | 4 |  |  |
  - Current smoking status | 3 |  | |
  - Smoking duration | 1 |  | [107] |
 Alcohol consumption | 1 |  | [57] |
 Citizenship (immigrant / non-immigrant) | 1 |  | [116] |
 Living in Northern vs Southern latitudes | 1 |  | [117] |
 Marital status | 1 |  | [107] |
Diabetes related | 54 | Â | Â |
 Hba1c related | 14 |  |  |
  - Hba1c level | 7 |  | |
  - Patterns, trends and trajectories | 6 |  | |
  - Hba1c variability | 2 |  | |
 Diabetes related complications | 13 |  |  |
  - Presence of albuminuria | 4 |  | |
  - Presence of complications e.g. cardiometabolic, microvascular diseases | 3 |  | |
  - Presence of diabetic retinopathy | 2 |  | |
  - Severity of albuminuria | 1 |  | [54] |
  - Presence of diabetic nephropathy | 1 |  | [130] |
  - Severity of diabetic neuropathy | 1 |  | [131] |
  - Severity of diabetic kidney disease | 1 |  | [132] |
  - Severity of diabetes related complications | 1 |  | [133] |
  - Medically attended hypoglycemia | 1 |  | [30] |
 Diabetes treatment related | 7 |  |  |
  - Types of anti-diabetic agents used | 5 |  | |
  - Dose of anti-diabetic agents | 1 |  | [136] |
  - Adherence to anti-diabetic agents | 1 |  | [31] |
 Other laboratory parameters | 5 |  |  |
  - Presence / levels of islet cells auto-immune antibodies levels | 4 |  | |
  - Glucose-dependent insulinotropic polypepide (GIP) and glucagon like peptide-1 (GLP-1) | 1 |  | [70] |
 Age at T2DM diagnosis | 5 |  | |
 Diabetes related risk factors | 5 |  |  |
  - Number of risk factors | 3 | Clinical risk groups | |
  - Total metabolic score | 2 |  | |
 Fasting plasma glucose | 3 |  |  |
  - Variability of fasting plasma glucose levels | 3 |  | |
  - Mean fasting plasma glucose levels | 2 |  | |
 Duration of T2DM | 4 |  | |
 Subtypes of T2DM | 1 | Ketosis prone T2DM or previously diagnosed T2DM with diabetic ketoacidosis [146] | [146] |
 Status of T2DM at cancer diagnosis | 1 | Insulin resistant /insulin sensitive [24] | [24] |
 Characteristics of T2DM | 1 | Ketosis | [134] |
 Severity of diabetes distress | 1 | 17-item Diabetes Distress Scale scores [147] | [147] |
 Presence of metabolic disorder | 1 |  | [10] |
 Reasons for not participating in diabetes related progam | 1 |  | [148] |
Non-diabetes medical related factors | 18 | Â | Â |
 Chronic kidney disease | 6 |  |  |
  - Severity of chronic kidney disease | 4 |  | |
  - Presence of chronic kidney disease | 2 |  | |
 Hypertension related | 5 |  |  |
  - Blood pressure control, variability | 2 |  | |
  - Presence of hypertension | 1 |  | [102] |
  - Presence of resistance hypertension | 1 |  | [71] |
  - Number of anti-hypertensive agents | 1 |  | [71] |
 Cardiovascular related | 3 |  |  |
  - Number of cardiovascular risk factors | 1 |  | [50] |
  - Presence of atherosclerosis | 1 |  | [51] |
  - Echocardiographic variables | 1 |  | [102] |
 Physical function status related | 2 |  |  |
  - Physical functional status | 1 |  | [151] |
  - Frailty | 1 |  | [152] |
 Laboratory related parameters | 2 |  |  |
  - Blood biochemistries / full blood count | 1 |  | [26] |
  - Low-density lipoprotein (LDL) levels | 1 |  | [63] |
 Comorbidities of patients (overall) | 1 |  | [128] |
 Overall medication usage | 1 |  | [26] |
 Severity of pain | 1 |  | [131] |
 Microaneurysm turnover and for the central retinal thickness | 1 |  | [153] |
Psychiatric or psychological related factors | 16 | Â | Â |
 Depression or anxiety related | 9 |  |  |
  - Presence and severity of depression and anxiety symptoms | 3 |  | |
  - Severity of depression | 3 |  | |
  - Presence of depression | 2 |  | |
  - Patterns of depression | 1 | Persistant depressive symptoms, new depressive symptoms, remitted depressive symptoms, no or few depressive symptoms [29] | [29] |
  - Severity of anxiety symptoms | 1 |  | [46] |
 Other psychiatric disorders / symptoms related factors | 5 |  |  |
  - Presence of sleep disturbance, fatigue | 2 |  | |
  - Number of psychiatric conditions | 1 |  | [22] |
  - Severity of psychiatric symptoms | 1 | Brief Psychiatric Rating Scale score | [35] |
  - Cognitive status | 1 |  | [62] |
 Health related quality of life | 3 |  | |
 Patient perceptions related factors | 2 |  |  |
  - Illness perception | 1 |  | [158] |
  - Perceived self-efficacy | 1 |  | [35] |
  - Perceived social support | 1 |  | [35] |
 Personality traits differences | 1 |  | [159] |
Healthcare systems related | 6 | Â | Â |
 Type of healthcare utilization | 2 |  | |
 Type or specialty of care provider | 2 |  | |
 Hospital admission | 1 |  | [53] |
 Frequency of emergency department presentation | 1 |  | [162] |